CAWR Clinical Studies

Question 1

Iannitti Number of Patients

Answer 1

74

Question 2

Iannitti Product

Answer 2

XenMatrix AB

Question 3

Iannitti follow up

Answer 3

6 months

Question 4

Iannitti recurrence rate

Answer 4

5.4%

Question 5

Iannitti General Message

Answer 5

Rifampin and Minocycline coated graft was associated with a low rate of post op infections and complications

Question 6

Roth Product

Answer 6

Phasix

Question 7

Roth recurrence rate

Answer 7

9%

Question 8

Roth General Message

Answer 8

High risk ventral hernia repairs repaired with Phasix demonstrated positive outcomes and low incidence of hernia recurrence at 18 month

Question 9

Badylak Product

Answer 9

Phasix

Question 10

Badylak Message

Answer 10

Phasix provides immediate reinforcement and strength while gradually transferring load bearing responsibilities to the body wall

Question 11

Brynes/Croston Product

Answer 11

XenMatri AB

Question 12

Brynes/Croston General Message

Answer 12

Complex ventral hernias can be repaired with a low recurrence rate

Question 13

Brynes/Croston Recurrence Rate

Answer 13

7.2%

Question 14

Brynes/Croston Follow Up

Answer 14

30.6 months

Question 15

Pomahac Product

Answer 15

Xenmatrix

Question 16

Pomahac follow up

Answer 16

40.1 months

Question 17

Pomahac recurrence rate

Answer 17

7%- wide range of grades

Question 18

Buell Product

Answer 18

Phasix

Question 19

Buell General Message

Answer 19

Phasix had shorter drain time, fewer complications and the product was cheaper

Question 20

Buell recurrence rate

Answer 20

6%

Question 21

Roth length of study

Answer 21

18 months